Delivery Routes of Topical Eyedrops Reaching the Posterior Segment of the Eye‐Recent Advances
Chemistry – A European Journal · 2025
DOI: 10.1002/chem.202502324 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Yuhong Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Ophthalmic Solutions, Drug Delivery Systems, Posterior Eye Segment. Die Arbeit nennt 68 Literaturangaben. Gefördert von: National Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Current topical eyedrop treatments for posterior segment diseases face significant challenges, including rapid tear clearance and ocular barrier limitations, which hinder effective drug delivery to target tissues in the posterior segment. To date, no eyedrop formulation has been clinically approved for the treatment of ocular fundus diseases. Eyedrops reach the posterior segment via two primary routes: the corneal route and the conjunctival routes, the latter comprising the conjunctival–vasculature route and the conjunctival–scleral route. This review summarizes recent advances in topical eyedrop therapies for ocular fundus diseases, with a focus on their delivery routes and the mechanisms by which they reach the posterior segment of eye. The cell‐penetrating homing peptides and lipid nanoparticle‐encapsulated eyedrops primarily reach the posterior segment via the corneal route; cell‐penetrating peptides and PepT‐1‐targeting ligands mainly utilize the conjunctival route; whereas chitosan nanoparticles, polymeric micelles, and supramolecular peptide‐based eyedrops can access the posterior segment via both routes. By systematically clarifying the pathways and mechanisms by which eyedrops formulations traverse ocular barriers, this review aims to provide a rational foundation for future research and development in posterior segment drug delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- CAS Center for Excellence in Nanoscience, CAS Key Laboratory For Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Beijing, China.
ORCID-Profile: Lei Wang
Förderung
- National Science Fund for Distinguished Young Scholars
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Postdoctoral Research Foundation of China
Zitieren
APA
Ye, Y., Zhang, Y., Zhao, P., Shen, Y., Hu, P., Wang, L., & Long, D. (2025). Delivery Routes of Topical Eyedrops Reaching the Posterior Segment of the Eye‐Recent Advances. Chemistry – A European Journal. https://doi.org/10.1002/chem.202502324
Vancouver
Ye Y, Zhang Y, Zhao P, Shen Y, Hu P, Wang L, et al. Delivery Routes of Topical Eyedrops Reaching the Posterior Segment of the Eye‐Recent Advances. Chemistry – A European Journal. 2025. doi:10.1002/chem.202502324
BibTeX
@article{Ye2025,
author = {Ye, Yuhong and Zhang, Ye and Zhao, Pan and Shen, Yaobang and Hu, Ping and Wang, Lei and Long, Da},
title = {Delivery Routes of Topical Eyedrops Reaching the Posterior Segment of the Eye‐Recent Advances},
journal = {Chemistry – A European Journal},
year = {2025},
doi = {10.1002/chem.202502324}
}
EUVIMED